About Aldeyra
Aldeyra is a company based in Lexington (United States) founded in 2004.. Aldeyra has raised $4.79 million across 6 funding rounds from investors including Hercules Capital, Perceptive Advisors and Sphera Fund. The company has 9 employees as of December 31, 2024. Aldeyra has completed 1 acquisition, including Helio Vision. Aldeyra offers products and services including RASP Modulator Platform and ADX-2191. Aldeyra operates in a competitive market with competitors including Annexon, Nicox, Gyroscope, MeiraGTx and Alimera Sciences, among others.
- Headquarter Lexington, United States
- Employees 9 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aldeyra Therapeutics, Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-55.85 M-48.77as on Dec 31, 2024
-
EBITDA
$-59.87 M-40.76as on Dec 31, 2024
-
Total Equity Funding
$4.79 M (USD)
in 6 rounds
-
Latest Funding Round
-
Investors
Hercules Capital
& 3 more
-
Employee Count
9
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aldeyra
Aldeyra is a publicly listed company on the NASDAQ with ticker symbol ALDX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aldeyra
Aldeyra offers a comprehensive portfolio of products and services, including RASP Modulator Platform and ADX-2191. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Modulates immunological systems to inhibit inflammatory cells in diseases.
Treats signs and symptoms of dry eye disease through targeted mechanisms.
Unlock access to complete
Unlock access to complete
Funding Insights of Aldeyra
Aldeyra has successfully raised a total of $4.79M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Last Round
-
First Round
First Round
(03 Jan 2013)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2020 | Amount | Post-IPO - Aldeyra | Valuation |
investors |
|
| Mar, 2019 | Amount | Debt – Conventional - Aldeyra | Valuation |
investors |
|
| Feb, 2019 | Amount | Post-IPO - Aldeyra | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aldeyra
Aldeyra has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Hercules Capital, Perceptive Advisors and Sphera Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt financing is provided to companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Manages hedge funds with long/short equity and real estate strategies for investors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aldeyra
Aldeyra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Helio Vision. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of small molecule based therapeutics for the treatment of eye diseases
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Aldeyra
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aldeyra Comparisons
Competitors of Aldeyra
Aldeyra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Annexon, Nicox, Gyroscope, MeiraGTx and Alimera Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| domain | founded_year | HQ Location |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| domain | founded_year | HQ Location |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
|
| domain | founded_year | HQ Location |
Ophthalmic pharmaceuticals for diabetic macular edema are developed and commercialized.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aldeyra
Frequently Asked Questions about Aldeyra
When was Aldeyra founded?
Aldeyra was founded in 2004 and raised its 1st funding round 9 years after it was founded.
Where is Aldeyra located?
Aldeyra is headquartered in Lexington, United States. It is registered at Lexington, Kentucky, United States.
Is Aldeyra a funded company?
Aldeyra is a funded company, having raised a total of $4.79M across 6 funding rounds to date. The company's 1st funding round was a Post-IPO of $10M, raised on Jan 03, 2013.
How many employees does Aldeyra have?
As of Dec 31, 2024, the latest employee count at Aldeyra is 9.
What does Aldeyra do?
Aldeyra was founded in 2004 and is based in Lexington, United States. Operations are conducted in the biotechnology sector, where drug candidates are developed to address immune-mediated diseases. The pipeline targets inflammatory cells associated with ocular and systemic conditions, including Reproxalap for dry eye disease and allergic conjunctivitis, as well as ADX-2191 for proliferative vitreoretinopathy and other programs.
Who are the top competitors of Aldeyra?
Aldeyra's top competitors include Annexon, Alimera Sciences and MeiraGTx.
What products or services does Aldeyra offer?
Aldeyra offers RASP Modulator Platform and ADX-2191.
Is Aldeyra publicly traded?
Yes, Aldeyra is publicly traded on NASDAQ under the ticker symbol ALDX.
How many acquisitions has Aldeyra made?
Aldeyra has made 1 acquisition, including Helio Vision.
Who are Aldeyra's investors?
Aldeyra has 4 investors. Key investors include Hercules Capital, Perceptive Advisors, Sphera Fund, and DAFNA Capital Management.
What is Aldeyra's ticker symbol?
The ticker symbol of Aldeyra is ALDX on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.